As MLL does not have any intrinsic DNA-binding capability, the SARNP–MLL fusion may confer this action through SARNP's SAP DNA-binding motif (Figure 2), potentially resulting in altered gene expression, a hallmark of cancer development [163]. Here, KMT2A is linked to cancer.